Summary of the virological and immunological status of “viremic” and “controller” vaccinated monkeys during the chronic phase of infection (weeks 22–74).

aMonkey AG269 died at week 26 after challenge and was excluded from the analysis. Monkey AF134 died at week 46 after challenge.
bAccording to their virological status during chronic infection, vaccinated monkeys were grouped as viremic (V) and Controllers (C). The numbers in parenthesis indicate the range (minimum-maximum value) of plasma viral RNA (Eq/ml). The p value indicates the statistical difference between the two groups.
cNumbers in parenthesis indicate the range (minimum-maximum value) of CD4+ T cell counts/mmc. The p value indicates the statistical difference between the two groups.
dNumbers in parenthesis indicate the range (minimum-maximum value) of anti-Tat IgG antibody titers. The p value indicates the statistical difference between the two groups.
eThis monkey was negative for plasma viremia at 2 out 9 time points during the chronic infection.
Summary of the virological and immunological status of “viremic” and “controller” vaccinated monkeys during the chronic phase of infection (weeks 22–74).